Cornelius A. Thiels (@thielsca) 's Twitter Profile
Cornelius A. Thiels

@thielsca

🇩🇪, 🇺🇸, Dad, Surgical Oncologist focusing on Sarcoma, NET & Pancreas Cancer. ❤️ 🤖🔪, AI &🦀🔬

ID: 1722846806

linkhttp://surgicalai2.com calendar_today02-09-2013 16:38:35

1,1K Tweet

1,1K Followers

1,1K Following

Thor Halfdanarson (@oncothor) 's Twitter Profile Photo

Just a reminder that SSTR PET imaging does not reliably identify small multifocal sbNETs and regional nodal involvement. Surprising? Of course not... Sometimes one just needs to do the relatively simple studies to know for sure...😉 onlinelibrary.wiley.com/doi/10.1002/js…

Just a reminder that SSTR PET imaging does not reliably identify small multifocal sbNETs and regional nodal involvement. Surprising? Of course not... 
Sometimes one just needs to do the relatively simple studies to know for sure...😉

onlinelibrary.wiley.com/doi/10.1002/js…
Mayo Clinic Department of Surgery (@mayoclinicsurg) 's Twitter Profile Photo

The Mayo Clinic Department of Surgery #CSGO Fellowship is an opportunity for qualified general surgeons to experience a two-year clinical and research fellowship at the #1 hospital in the U.S. Learn more: mayocl.in/3CZQXLJ Society of Surgical Oncology Cornelius A. Thiels @DrSusWarner Patrick Starlinger_TELL International

Cornelius A. Thiels (@thielsca) 's Twitter Profile Photo

This is really nice point! At least 2 branches is ideal, can occasionally can peel more proximal nodes off SMA/SMV proximally but agree level IV nodes typically do not benefit from local therapy… except maybe EBRT Thor Halfdanarson?

JAMA Surgery (@jamasurgery) 's Twitter Profile Photo

In an analysis of national Medicare claims data, there were no detectable differences in 30-day mortality, readmission, or length of stay between patients treated with allopathic vs osteopathic surgeons. ja.ma/42g2fpw Tara Russell Yusuke Tsugawa

In an analysis of national Medicare claims data, there were no detectable differences in 30-day mortality, readmission, or length of stay between patients treated with allopathic vs osteopathic surgeons. ja.ma/42g2fpw <a href="/TR_284/">Tara Russell</a> <a href="/Yusuke_Tsugawa/">Yusuke Tsugawa</a>
Cornelius A. Thiels (@thielsca) 's Twitter Profile Photo

Congrats Mayo Clinic Department of Surgery HPB fellow Hala for her acceptance at 2025 ASA meeting! “Imaging Based Surgical Site Infection Detection Using Artificial Intelligence” Annals of Surgery Hojjat Salehinejad, Ph.D., SMIEEE Liz Habermann, PhD MPH and surgicalai2.com lab team! (Image credit: GenAi)

Congrats <a href="/MayoClinicSurg/">Mayo Clinic Department of Surgery</a> HPB fellow <a href="/HalaMuaddi/">Hala</a> for her acceptance at 2025 ASA meeting! 

“Imaging Based Surgical Site Infection Detection Using Artificial Intelligence”

<a href="/AnnalsofSurgery/">Annals of Surgery</a> <a href="/SalehinejadH/">Hojjat Salehinejad, Ph.D., SMIEEE</a> <a href="/EBHabermann/">Liz Habermann, PhD MPH</a> and surgicalai2.com lab team! (Image credit: GenAi)
Mayo Clinic Department of Surgery (@mayoclinicsurg) 's Twitter Profile Photo

Learn more about the Mayo Clinic Breast Surgical Oncology and Complex General Surgery Oncology Fellowships at #SSO2025. Program leaders, faculty and current fellows will be at the Tampa Convention Center Mar. 27-28. #SurgEd #SurgicalFellowship

Learn more about the <a href="/MayoClinic/">Mayo Clinic</a> Breast Surgical Oncology and Complex General Surgery Oncology Fellowships at #SSO2025. Program leaders, faculty and current fellows will be at the Tampa Convention Center Mar. 27-28. #SurgEd #SurgicalFellowship
Chris Varghese (@chrisvarghese98) 's Twitter Profile Photo

Some improvements in OS and DFS in recent tx era, but long way to go! 📈 👉 We confirm most recurrences occur early, within <3y 👉 Conditional survival in up to >2/3 of patients after 3y (accounting for death as competing risk)

Some improvements in OS and DFS in recent tx era, but long way to go! 📈

👉 We confirm most recurrences occur early, within &lt;3y
👉 Conditional survival in up to &gt;2/3 of patients after 3y (accounting for death as competing risk)